Increased expression of MKLN1-AS was associated with unfavorable outcomes in individuals with PDAC, aligning with earlier research indicating the involvement of MKLN1-AS in the advancement of hepatocellular carcinoma (Gao et al. 2020). The gene discussed is MKLN1; the disease is hepatocellular carcinoma.